2 months ago
STIM
AnalystsWilliam PlovanicWilliam Plovanic's Stock Forecasts
AnalystsWilliam Plovanic
Analyst Ranking
Top 14%
#658 out of 4868 analysts
Average Return
+5.95%
Win Rate
44%57 out of 131
Risk vs Reward
Poor
Good
William Plovanic's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Neuronetics IncSTIM | +492.69% | $0.74 | $4.38 | 2024-08-12 - 2025-04-30 | Strong Buy |
Transmedics Group IncTMDX | +243.26% | $22.17 | $76.10 | 2022-03-16 - 2023-03-16 | Strong Buy |
Bioventus IncBVS | +128.57% | $5.11 | $11.68 | 2023-12-06 - 2024-12-06 | Strong Buy |
Y Mabs Therapeutics IncYMAB | +103.12% | $6.09 | $12.37 | 2023-07-24 - 2024-07-24 | Strong Buy |
Inari Medical IncNARI | +94.83% | $40.78 | $79.45 | 2024-04-11 - 2025-01-07 | Strong Buy |
William Plovanic Analyst Color
Get additional color on William Plovanic's coverage of popular stocks
3 months ago
DXCM
3 months ago
ATRC
3 months ago
CVRX
5 months ago
PODD
5 months ago
IRTC
5 months ago
CVRX
5 months ago
CBLL
5 months ago
BSX
5 months ago
ATRC
6 months ago
CBLL
6 months ago
BVS
6 months ago
ATRC
6 months ago
BSX
2 years ago
YMAB
2 years ago
SWAV
William Plovanic's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Edwards Lifesciences CorpEW | 23 | Hold | $75.00 | -0.65% | Maintains | 6 days ago |
Cvrx IncCVRX | 8 | Strong Buy | $18.00 | +145.90% | Maintains | 23 days ago |
Trisalus Life Sciences IncTLSI | 4 | Strong Buy | $11.00 | +114.42% | Maintains | a month ago |
Atricure IncATRC | 11 | Strong Buy | $52.00 | +73.85% | Maintains | a month ago |
Transmedics Group IncTMDX | 5 | Strong Buy | $104.00 | +13.03% | Maintains | 2 months ago |
Neuronetics IncSTIM | 3 | Strong Buy | $8.00 | +82.65% | Maintains | 2 months ago |
Tandem Diabetes Care IncTNDM | 3 | Strong Buy | $63.00 | +273.89% | Maintains | 2 months ago |
Ceribell IncCBLL | 4 | Strong Buy | $33.00 | +105.10% | Maintains | 2 months ago |
Dexcom IncDXCM | 5 | Strong Buy | $103.00 | +44.30% | Maintains | 3 months ago |
Nevro CorpNVRO | 12 | Hold | $5.85 | +0.17% | Maintains | 3 months ago |
Globus Medical IncGMED | 3 | Strong Buy | $101.00 | +40.73% | Maintains | 4 months ago |
Inari Medical IncNARI | 12 | Hold | $80.00 | +0.04% | Downgrades | 4 months ago |
Insulet CorpPODD | 3 | Strong Buy | $304.00 | +20.50% | Maintains | 5 months ago |
Irhythm Technologies IncIRTC | 9 | Strong Buy | $152.00 | +42.20% | Maintains | 5 months ago |
Boston Scientific CorpBSX | 9 | Strong Buy | $101.00 | -1.82% | Maintains | 5 months ago |
Bioventus IncBVS | 4 | Strong Buy | $15.00 | +105.20% | Maintains | 6 months ago |
Angiodynamics IncANGO | 5 | Strong Buy | $12.00 | +29.17% | Maintains | 7 months ago |
Zimmer Biomet Holdings IncZBH | 2 | Hold | $115.00 | +11.60% | Maintains | 8 months ago |
Shockwave Medical IncSWAV | 6 | Hold | $335.00 | N/A | Downgrades | a year ago |
Penumbra IncPEN | 4 | Strong Buy | $284.00 | N/A | Reiterates | a year ago |
Alphatec Holdings IncATEC | 1 | Strong Buy | $25.00 | N/A | Maintains | a year ago |
Pulmonx CorpLUNG | 4 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Merit Medical Systems IncMMSI | 4 | Hold | $70.00 | N/A | Maintains | 2 years ago |
Staar Surgical CoSTAA | 5 | Hold | $48.00 | N/A | Downgrades | 2 years ago |
Y Mabs Therapeutics IncYMAB | 3 | Strong Buy | $22.00 | N/A | Maintains | 2 years ago |
Vapotherm IncVAPO | 2 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Acutus Medical IncAFIB | 4 | Hold | $3.00 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.